 | Cirex Pharmaceuticals Ltd | ||
| |||
| |||
porno
porno izle
porno doeda
ramadabet • slotica • leogrand • slotday • venombet • deobet • ritzbet • exonbet giriş • betwild • radissonbet • pashagaming giriş • palacebet giriş • maxwin • spinco giriş • betsin • betsalvador • palazzobet • royalbet • Royalbet • Palacebet • Grandpashabet giriş • casinofast • baywin giriş • deneme bonusu veren • Türk İfşa • Altyazılı Porno • bonus veren siteler • Deneme bonusu •
| |
Cirex Pharmaceuticals Ltd |
| Hetero House, H.no.8-3-166/7/1, Erragadda Hyderabad Ap Country: India Telephone: 3704923/24 Fax: N/A |  |
Top Import Product Information of Cirex Pharmaceuticals Ltd |
| HS Code | Product Description |
| 29151300 | Triethyl Ortho Formate |
| 29163190 | 2,3,4,5,6-penta Fluoro Benzoic Acid |
| 29163901 | 2,3,4,5,6 Penta Fluoro Benzoic Acid |
| 29163910 | 23456 Penta Fluoro Benzoic Acid |
| 29163990 | 23456 Penta Fluoro Benzoic Acid |
Import Shipment database details of Cirex Pharmaceuticals Ltd |
| Date | HS Code | Description | India Port | Foreign Port | Foreign Country | Quantity | Unit of Quantity |
| 15-3-2003 | 29151300 | Triethyl Ortho Formate | Madras Sea | Cn | India | 1080 | Kgs |
| 15-3-2003 | 29163190 | 2,3,4,5,6-penta Fluoro Benzoic Acid | Madras Sea | Jp | India | 1200 | Kgs |
| 15-2-2003 | 29163190 | 2,3,4,5,6-penta Fluoro Benzoic Acid | Madras Sea | Jp | India | 1200 | Kgs |
| 15-1-2003 | 29163901 | 2,3,4,5,6 Penta Fluoro Benzoic Acid | Madras Sea | Jp | India | 800 | Kgs |
| 08-12-2004 | 29163910 | 23456 Penta Fluoro Benzoic Acid | Madras Sea | India | 500 | Kgs | |
| 23-4-2004 | 29163990 | 23456 Penta Fluoro Benzoic Acid | Madras Sea | India | 400 | Kgs | |
Importers in similar top 5 hs codes |
| » Transpek Industry Limited » Matrix Laboratories Ltd » Nagarjuna Agrichem Ltd » Ranbaxy Fine Chemicals Ltd » Alpha Organics Pvt. Ltd |
List of other Alphabets |
 | A, B, C<< , D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R, S, T, U, V, W, X, Y, Z |
| Home | About us | Services | Contact us | Sitemap | Inquiry Basket(0) | Send Inquiry |